)
Rainbow Children's Medicare (RAINBOW) investor relations material
Rainbow Children's Medicare Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved 33% year-on-year revenue growth in Q1 FY27, reaching INR 4,700 million, with PAT up 16% to INR 625 million and EBITDA up 30% to INR 1,346 million, driven by strong demand across core specialties and balanced contributions from mature and new hospitals.
Operational expansion continued with 24 hospitals across 9 cities, 2,565 beds, and over 1,075 doctors, including new agreements in Mumbai, Nellore, and Guntur, marking entry into Western India and strengthening Andhra Pradesh presence.
Recognized for clinical excellence with multiple JCI and NABH accreditations, awards for leadership and workplace practices, and notable achievements in complex pediatric cases.
Five-year plan to add 2,500 beds, targeting a total network capacity of 5,000 beds with INR 2,200 crore CapEx.
Unaudited standalone and consolidated financial results for Q1 FY27 were approved by the Board of Directors on July 30, 2026.
Financial highlights
Q1 FY27 operating revenue reached INR 4,699.9 million, up 33% year-on-year, with EBITDA at INR 1,346.5 million and a margin of 28.6%.
Profit after tax was INR 625.4 million, a 16% year-on-year increase.
Inpatient discharges, outpatient consultations, and deliveries grew by 28%, 25%, and 23% respectively.
Total expenses rose 32% year-on-year, mainly due to higher employee benefits and professional fees.
Organic revenue growth (excluding acquisitions) was 24% year-on-year.
Outlook and guidance
Expansion plans target 3,725 beds by FY29, with new hospitals in Coimbatore, Gurugram, Indore, Mumbai, and Pune, and completion of the Malad, Mumbai hospital expected by Q2 FY27.
Targeting to double top-line revenue over the next four years, implying a 20% CAGR.
EBITDA margin guidance for FY27 and FY28 is 24%-25% pre-Ind AS, despite recent margin pressures from rapid bed additions.
Acquisition of a 64% stake in Super Prime Medical Care LLP (Nellore, Andhra Pradesh) is expected to close in Q2 FY27.
Focus on replicating the hub-and-spoke model in new regions and tier-2 cities.
- Q4 FY26 saw record growth, major expansion, and a proposed ₹3.50/share dividend.RAINBOW
Q4 25/26 - Q3 FY26 revenue up 12%, profit rises, network expands, and new CEO appointed.RAINBOW
Q3 25/26 - Q2 FY26 revenue up 6.5% YoY, major acquisitions and new CEO support strong growth outlook.RAINBOW
Q2 25/26 - Q1 FY25 revenue up 15% YoY, EBITDA up 6.9%, with expansion, capex, and top accreditations.RAINBOW
Q1 24/25 - Q2 FY25 saw 25% revenue and profit growth, strong margins, and continued expansion.RAINBOW
Q2 24/25 - Q3 FY25 revenue up 18.5% YoY, EBITDA up 14%, and new ESOP scheme approved.RAINBOW
Q3 24/25 - FY25 revenue up 17% YoY, margins strong, dividend proposed, and major expansion planned.RAINBOW
Q4 24/25 - Q1 FY26 saw 6.9% revenue growth, 35.4% higher net profit, and ongoing network expansion.RAINBOW
Q1 25/26
Next Rainbow Children's Medicare earnings date
Next Rainbow Children's Medicare earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage